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VE-cadherinDisruption of retinoic acid signaling causes a variety of pharyngeal arch artery and great vessel defects, as
well as malformations in many other tissues, including those derived from the pharyngeal endoderm. Previ-
ous studies implied that arch artery defects in the context of defective RA signaling occur secondary to pha-
ryngeal pouch segmentation defects, although this model has never been experimentally veriﬁed. In this
study, we examined arch artery morphogenesis during mouse development, and the role of RA in this pro-
cess. We show in normal embryos that the arch arteries form by vasculogenic differentiation of pharyngeal
mesoderm. Using various genetic backgrounds and tissue-speciﬁc mutation approaches, we segregate pha-
ryngeal arch artery and pharyngeal pouch defects in RA receptor mutants, and show that RA signal transduc-
tion only in pharyngeal mesoderm is required for arch artery formation. RA does not control pharyngeal
mesodermal differentiation to endothelium, but instead promotes the aggregation of endothelial cells into
nascent vessels. Expression of VE-cadherin was substantially reduced in RAR mutants, and this deﬁciency
may underlie the arch artery defects. The consequences of disrupted mesodermal and endodermal RA signal-
ing were restricted to the 4th and 6th arch arteries and to the 4th pharyngeal pouch, respectively, suggesting
that different regulatory mechanisms control the formation of the more anterior arch arteries and pouches.
© 2011 Elsevier Inc. All rights reserved.Introduction
Pharyngeal arch arteries are transient conduits between the heart
and systemic circulation during early embryogenesis. One arch artery
forms within each pharyngeal arch as the arches themselves form se-
quentially in a rostral to caudal direction (Hiruma et al., 2002). In nor-
mal mouse embryos at E9.5, the 1st arch arteries have already lost
their connections to the outﬂow tract of the heart and the 2nd and
3rd arch arteries carry cardiac output; the 4th and 6th arch arteries
have not yet formed at this time. By E10.5, the 2nd arch arteries are
no longer connected to the outﬂow tract, and the 3rd, 4th, and 6th
arch arteries carry blood ﬂow. Starting from E11, these become asym-
metrically reorganized into the great vessels of the heart. Defects in
arch artery formation and reorganization lead to a variety of congen-
ital great vessel defects that are prominent in the human population.
The endothelium of the arch arteries is derived from pharyngeal
mesoderm, whereas their smooth muscle is derived from neural
crest. Between each pharyngeal arch, the pharyngeal endoderm is or-
ganized into pouches that form or contribute to several pharyngeal
organs, including the thymus and parathyroids (3rd pouch) and the
ultimobranchial bodies (4th pouch). Pharyngeal organ and arch ar-
tery defects often occur together, possibly because of the closerights reserved.physical relation of the pharyngeal pouches and arch arteries and
their potential interactions during development.
Retinoic acid (RA) is a vitamin A derivative that is widely used as a
signaling molecule in vertebrate development. The RA receptor is a
heterodimer of RAR and RXR, both members of the nuclear receptor
family of ligand-dependent transcription factors. In humans and
mice, there are three RAR genes and three RXR genes (identiﬁed as
α, β, and γ), and each gene gives rise to two major isoforms (num-
bered 1 and 2) based on alternative promoter utilization. Great vessel
defects occur in many experimental models of compromised RA sig-
naling, including several different mouse mutant backgrounds
(Dupe et al., 1999; Lee et al., 1997; Mendelsohn et al., 1994;
Niederreither et al., 2003), nutritional vitamin A deﬁciency in rat em-
bryos (Wilson andWarkany, 1949), and treatment of mouse embryos
with a pan-RAR antagonist (Wendling et al., 2000). Many additional
malformations occur in these models as well. A primary target of RA
signaling is the pharyngeal endoderm, and many perturbations of
RA signaling cause defective 3rd and 4th pharyngeal pouch formation
and consequent pharyngeal organ defects (Bayha et al., 2009;
Kopinke et al., 2006; Matt et al., 2003; Mulder et al., 1998;
Niederreither et al., 2003; Wendling et al., 2000). Arch artery defects
in embryos with compromised RA signaling have been concluded to
result indirectly from an initial perturbation in pharyngeal endoderm
structure (Wendling et al., 2000) or signals (Mark et al., 2004, 2009).
A limitation of past studies has been the lack of conditional muta-
genesis approaches to directly test the tissue-speciﬁc functions of RA
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several RA receptor mutant backgrounds, with particular attention
to addressing the previously-implied explanation for arch artery
abnormalities as resulting indirectly from primary defects in the
pharyngeal endoderm. Using tissue-speciﬁc mutagenesis, we have
segregated pharyngeal artery and pouch defects seen in RAR mutant
embryos. We conﬁrm that RA signaling in pharyngeal endoderm
supports pharyngeal pouch morphogenesis. For arch artery morpho-
genesis, however, RA receptor function is independently required in
pharyngeal mesoderm, where it promotes the assembly of endothelial
precursors into nascent blood vessels.
Materials and methods
Mice
All mouse alleles used in this study have been previously reported:
Rara1 null (Li et al., 1993), Rarb null (Luo et al., 1995), conditional
Rxra (Chen et al., 1998), CAGG-Cre (Hayashi and McMahon, 2002),
Mesp1Cre (Saga et al., 1999), Tie2Cre (Kisanuki et al., 2001), Foxa2Cremcm
(Park et al., 2008), R26R (Soriano, 1999), and conditional Rara403
(Rajaii et al., 2008). Noon of the day of observation of a copulatory
plug was deﬁned as developmental day E0.5. Embryos were isolated
as close as possible to 6:00 AM, noon, 6:00 PM, or midnight when spe-
ciﬁc developmental stages were obtained. The 4th and 6th arch arteries
are not present at E9.5 and are functional at E10.5; similarly, the 3rd and
4th pharyngeal pouches are not morphologically apparent at E9.5 but
are evident at E9.75 and expanded at E10.0.
Tamoxifen-induced gene knockout
Pregnant femaleswere treatedwith a single intraperitoneal injection
of tamoxifen (75 mg/kg; Sigma T5648) dissolved in corn oil. For tempo-
ral analysis using CAGG-Cre, females were treated at deﬁned times. For
endoderm-speciﬁc recombination using Foxa2Cremcm, females were
treated at E6.75 as described previously (Park et al., 2008).
LacZ staining
Embryos were isolated and ﬁxed in 0.2% glutaraldehyde followed
by staining in Xgal solution as whole mount preparations. Embryos
were then embedded and parafﬁn sectioned, followed by nuclear
fast red counterstaining.
Ink injection
Embryos were isolated at E10.5 and placed in ice cold PBS. India
ink (Martin's Bombay Black, diluted in PBS as needed) was injected
into the ventricle through a pulled glass micropipet until the small
vessels were stained. The embryos were then ﬁxed in 4% paraformal-
dehyde in PBS overnight.
Immunohistochemistry and immunoﬂuorescence
Embryos were isolated and ﬁxed in 4% paraformaldehyde in PBS
overnight, then dehydrated and embedded in parafﬁn or OCT for sec-
tioning. Primary antibodies used in this study were calcitonin (Abcam
ab45007), PECAM1 (BD Pharmagen 553370), Vegfr2/Flk1 (R&D Sys-
tems AF644), SM22 (Abcam ab10135), and VE-cadherin (BD Pharma-
gen 550548). For immunohistochemistry, the sections were followed
by biotinylated secondary antibodies (Santa Cruz) and HRP-coupled
streptavidin (Jackson Immunologicals), and DAB staining (Invitro-
gen) and hematoxylin counterstaining. For immunoﬂuorescence,
chromophore-labeled secondary antibodies (Invitrogen) were used.In situ hybridization
As described previously (Li et al., 2010), embryos were ﬁxed in 4%
PFA and parafﬁn-sectioned or processed as whole mount. ISH probe
sequences included for parathyroid hormone positions 29–535 of
NM_020623.2 (provided by N. Manley) and for Pax1 positions
1027–1466 of NM_008780.2. Probes were labeled by digoxygenin
(DIG, Roche) and signal was detected by AP-coupled anti-DIG prima-
ry antibody and BM Purple substrate.
Cytospin
The 4th and 6th pharyngeal arch regions of E10.0 embryos were
isolated as single tissue fragments in cold PBS by manual dissection.
Tissue was dissociated using 1 mg/ml collagenase IV digested for
10 min at 37 °C, then washed with PBS. The cell suspensions were
resuspended in 0.4 ml PBS and deposited onto slides using a Cytospin
apparatus, then ﬁxed in 4% paraformaldehyde in PBS at room temper-
ature for 15 min, and labeled by immunoﬂuorescence staining.
Results
RA regulates the initial formation of pharyngeal arch arteries
Embryos lacking the α1 isoform of the Rara gene are completely
normal, whereas embryos globally lacking RARα1 plus all isoforms of
the Rarb gene (designated as Rara1/Rarb) or lacking RARα1 and RXRα
(Rara1/Rxra) have a variety of great vessel malformations (Lee et al.,
1997); similar vascular defects have been observed in other contexts
where RA signaling has been disrupted (Mendelsohn et al., 1994;
Niederreither et al., 2003; Wendling et al., 2000; Wilson and
Warkany, 1949).We injected ink into the hearts of E10.5 embryos to vi-
sualize the developing vasculature in the Rara1/Rarb mutant back-
ground. In normal embryos at this stage, the 3rd, 4th, and 6th arch
arteries are present bilaterally. In all Rara1/Rarb mutants, we observed
bilateral absence or hypoplasia of the 4th and/or 6th arch arteries
(Fig. 1A–B, Table 1); 3rd arch artery defects were never observed. In
most cases, one vessel was missing on each side, although occasionally,
the 4th and 6th arch arteries were both missing on one side (Fig. 1B)
with only one missing on the other side. There was no overall bias in
which of the two vessels was impacted and there was no concordance
in which vessels were missing from one side of an embryo to the
other. The spectrum and frequency of these arterial defects at E10.5
are consistent with our prior inferences based on the mature vascular
pattern at E14.5 (Lee et al., 1997). These observations show that the
great vessel defects are caused by compromised early formation of the
arch arteries.
The CAGG-Cre transgene (Hayashi and McMahon, 2002) expresses
tamoxifen-dependent Cre recombinase in a ubiquitous manner. In a
previous study, we combined CAGG-Cre with a conditional Rxra allele
and documented the time course of elimination of RXRα protein fol-
lowing a single dose of tamoxifen (Li et al., 2010). We combined the
CAGG-Cre line with the conditional Rxra allele and with global deﬁ-
ciency of Rara1 to deﬁne the temporal requirement for RAR function
in arch artery development. When RA receptor function was ablated
prior to E9.5, approx. 60% of CAGG-Cre/Rara1/Rxra conditional mutant
embryos had 4th or 6th arch artery defects at E10.5 (Table 1); a sim-
ilar frequency of great vessel defects was also seen when embryos
were analyzed by histology at E14.5 (not shown). 3rd arch artery de-
fects were never observed in CAGG-Cre/Rara1/Rxra embryos. The in-
complete penetrance of 4th and 6th arch artery defects is explained
by litter to litter variation in Rxra gene recombination efﬁciency asso-
ciated with tamoxifen treatment, and by the observation that great
vessel defects are not fully penetrant in the global Rara1/Rxra double
mutant background. However, when RA signaling was compromised
starting at E10.5, all embryos were normal (Table 1). Thus, RA
Fig. 1. Pharyngeal morphogenesis in RAR mutants. Upper row images are of control embryos, lower row is of Rara1/Rarb global mutants. A,B, Arch artery organization in E10.5 em-
bryos visualized by ink injection. In this mutant (B), note the absence of the 4th and 6th arch arteries (indicated by asterisks). A′,B′, Frontal sections of the same embryos as in panels
A and B, showing normal 3rd pouch but defective 4th pouch formation in a mutant (B′), and also showing the absence of the 4th and 6th arch arteries. This example of defective 4th
pouch formation is of an intermediate severity; in other mutant embryos there was no 4th pouch formed whatsoever. C,D, In situ hybridization at E10.5 for Pax1, a marker of the 3rd
pouch at this stage. E,F, In situ hybridization at E18.5 for parathyroid hormone (PTH), a marker of the parathyroids (arrows); because of section angle, only one parathyroid in each
embryo is shown in full size. G,H, Immunohistochemical detection of calcitonin (CT) at E18.5 in the thyroids; arrows point to selected scattered positive cells in the control embryo,
whereas the mutant is missing all such cells. Numbers, 3rd, 4th, 6th arch arteries; p3 and p4, 3rd and 4th pharyngeal pouches; (p4), a hypoplastic 4th pouch; dAo, dorsal aorta; OFT,
outﬂow tract.
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tween E9.5 and E10.5, the period during which these arteries form.
4th Pharyngeal pouch defects in RA receptor mutants
To further study pharyngeal development, frontal sections of
Rara1/Rarb double global mutant embryos at E10.5 were compared
with littermates. In all cases, the 3rd arch arteries were properly
formed, whereas missing or extremely hypoplastic 4th and/or 6th
arch arteries were readily observed. (Fig. 1A′–B′).
This analysis also allowed us to examine the organization of the
pharyngeal pouches. The 3rd pouch was always present in Rara1/
Rarbmutants (Fig. 1A′–B′), and Pax1, a 3rd pouch endodermal marker
at this stage, was normally expressed (Fig. 1C–D). The thymus and
parathyroids originate from the 3rd pouch; our previous analysis of
Rara1/Rarb mutants showed normal thymic development (Lee et al.,Table 1
Arch artery defects at E10.5 assessed by ink injection.
Genotype Embryos Bilateral defects
Rara1/Rarb (global) 12 12 100
CAGG-Cre/Rara1/Rxra⁎
E8.5 12 4 33
E9.5 18 4 22
E10.5† 8 0 0
Wnt1Cre‡
Rara403 14 0 0
Foxa2Cremcm§
Rara1/Rxra 23 0 0
Rara403 28 3 11
Mesp1Cre
Rara1/Rxra 13 7 54
Rara403 16 16 100
Tie2Cre
Rara1/Rxra 14 0 0
Rara403 22 0 0
Frequency of arch artery defects in various RAR mutant backgrounds, assessed at E10.5 by i
defects were found, and whether such defects were bilateral or unilateral.
⁎ The stages indicated represent the onset of RAR-RXR deﬁciency. CAGG-Cre mice were tr
al., 2010), RXRα protein is essentially eliminated 24 h after tamoxifen injection.
† For CAGG-Cre/Rara1/Rxra mice treated with tamoxifen at E9.5 (receptor deﬁciency start
E14.5 embryos were also analyzed; none of 12 embryos had any great vessel defect.
‡ A previous study (Jiang et al., 2002) showed that Wnt1Cre/Rara1/Rxra mutants also had
§ All Foxa2Cremcm embryos were treated with tamoxifen at E6.75.1997), and using parathyroid hormone as a marker, we observed nor-
mal parathyroid formation in all E18.5 embryos (Fig. 1E–F). These re-
sults collectively indicate that 3rd pouch development occurs
normally in Rara1/Rarb mutants.
In contrast, in all E10.5 Rara1/Rarbmutants, the 4th pouches were
bilaterally compromised (Fig. 1A′–B′). In some cases, the 4th pouch
was partially formed, but in all cases there was some degree of fusion
of the 4th and 6th arches. The 4th pouch gives rise to the ultimobran-
chial body, which contributes the calcitonin-expressing cells that be-
come distributed within the thyroid (Kameda et al., 2007). In E18.5
Rara1/Rarb mutants, we observed an absence of calcitonin immuno-
reactivity in the thyroid, although the organ itself was of normal mor-
phology (Fig. 1G–H). These results conﬁrm the severity of the 4th
pouch defects in Rara1/Rarb mutants.
Because of the combined occurrence of caudal arch artery and
pouch defects in Rara1/Rarb mutants, it was possible that the 4thUnilateral defects Normal
% 0 0% 0 0%
% 3 25% 5 42%
% 8 44% 6 33%
% 0 0% 8 100%
% 0 0% 14 100%
% 0 0% 23 100%
% 7 25% 18 64%
% 2 15% 4 31%
% 0 0% 0 0%
% 0 0% 14 100%
% 0 0% 22 100%
nk injection. The table lists the number and of embryos in which 4th or 6th arch artery
eated with tamoxifen 24 h before the indicated times; as previously documented (Li et
ing from E10.5), to ensure that RA signaling is not also required later in development,
no cardiovascular phenotype.
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primary defect in the 4th pouch. However, in 6/7 CAGG-Cre/Rara1/
Rxra embryos with arch artery defects, pharyngeal pouchmorphology
was normal (Suppl. Fig. 1), although in one embryo, the 4th pouch
was poorly formed (not shown). Thus, the Rara1/Rxra mutant back-
ground shows that arch artery defects can occur in the context of ap-
parently normal pharyngeal pouch segmentation.
Segregation of RAR endodermal and mesodermal roles by conditional
mutagenesis
To further address the relationship between pharyngeal arch ar-
tery and pouch morphogenesis, we combined several tissue-speciﬁc
Cre drivers with the conditional Rxra allele coupled with global
Rara1 deﬁciency. We also combined the same Cre drivers with a con-
ditional dominant negative RAR allele (Rara403) expressed from the
R26R locus (Rajaii et al., 2008). This latter strategy relies on condition-
al expression of a dominant negative protein that should block all
RAR functions, rather than inactivation of subsets of RA receptor
genes followed by potentially slow turnover of preexisting protein;
it is therefore expected to more rapidly, efﬁciently, and comprehen-
sively block RA signaling relative to conditional single or double re-
ceptor gene disruption. Using Wnt1Cre, we showed previously that
neural crest-speciﬁc Rara1/Rxra conditional mutants had no cardio-
vascular defects (Jiang et al., 2002). In the present analysis, we ob-
served that Wnt1Cre/Rara403 mutants also had no cardiovascular
defects (Table 1). This conﬁrms that neural crest cells are not direct
targets for RA signaling during cardiac and arch artery development.
We used the tamoxifen-regulated Foxa2Cremcm line to address the
role of RA receptors in endoderm. As previously reported (Park et al.,
2008), following a single tamoxifen injection at E6.75, highly efﬁcient
endodermal recombination was evident (Suppl. Fig. 2B,D–G), al-
though there was some variation in efﬁciency among embryos and
between litters. Foxa2Cremcm/Rara1/Rxra conditional embryos were
similarly treated at E6.75. When isolated at E10.5 and evaluated by
ink injection, none of 23 treated conditional mutant embryos had
any arch artery defect (Table 1); similarly, as evaluated by histology,
none of 8 Foxa2Cremcm/Rara1/Rxra conditional embryos had defects in
any of the pharyngeal pouches (not shown). The frequent occurrence
of arch artery defects in global Rara1/Rxra mutants and in CAGG-Cre/
Rara1/Rxra conditional mutants, but not in Foxa2Cremcm/Rara1/Rxra
conditional mutants, implies that the combination of Rara1 and Rxra
mutation selectively interferes with arch artery formation, and does
so by action in a tissue other than pharyngeal endoderm.Fig. 2. Arch artery and pouch defects in tissue-speciﬁc RAR mutants. All embryos are at E10.
same embryos were taken to visualize pharyngeal organization. A, Control embryo. B,C, Two
hypoplastic 4th pouch, one has normal arch arteries (B) and one has an arch artery defect
pouches, and each has an arch artery defect. F, An Mesp1Cre/Rara403 mutant, showing normIn contrast, of 11 Foxa2Cremcm/Rara403 embryos treated with ta-
moxifen at E6.75 and isolated at E10.5, we often observed defective
4th pouch organization (Fig. 2B′–C′): 4 embryos had bilateral 4th
pouch defects, 5 had a unilateral 4th pouch defect, and 2 were nor-
mal. 3rd pouch formation in Foxa2Cremcm/Rara403 embryos was al-
ways normal. Immunostaining of the thyroid showed that half of
Foxa2Cremcm/Rara403 embryos at E18.5 had no calcitonin-expressing
cells (e.g., Suppl. Fig. 3B), whereas the other half had calcitonin ex-
pression ranging from highly deﬁcient to normal (not shown); this
is consistent with the frequency and severity of pouch defects seen
by histology at E10.5. These results demonstrate that RA signaling in
endoderm is important for 4th pouch segmentation, although with
reference to the lack of pouch defects in Foxa2Cremcm/Rara1/Rxra em-
bryos, this signaling does not require the RARα1 and RXRα receptors.
In most tamoxifen-treated Foxa2Cremcm/Rara403 embryos (18 of 28),
as assessed by ink injection, all pharyngeal arch arteries were present
bilaterally, and the only vascular alteration was a mild perturbation in
some of these in the position of the 4th arch artery (Fig. 2B), which
we attribute to the missing 4th pouch. In a smaller number of cases
(10 of 28), arch artery defects were observed (Fig. 2C, Table 1). Arch
artery abnormalities only occurred when there were 4th pouch de-
fects, but we found several examples of normal arch artery formation
with defective 4th pouch organization (e.g., Fig. 2B,B′). Endodermal
perturbation of RA signaling therefore can result in arch artery de-
fects, but 4th pharyngeal pouch disruption does not invariably result
in arterial defects.
In parallel, we used Mesp1Cre (Saga et al., 1999), which achieves
highly efﬁcient and speciﬁc recombination in pharyngeal mesoderm
starting from very early stages (Suppl. Fig. 2A,C). As assessed by ink
injection at E10.5, every Mesp1Cre/Rara403 embryo exhibited hypo-
plastic or absent 4th or 6th arch arteries, and always bilaterally
(Table 1), and absent 4th or 6th arch arteries were observed in
most (9 of 13) Mesp1Cre/RARa1/RXRa embryos (Table 1, Fig. 2D–F).
Similar to global Rara1/Rarb mutants, 4th vs. 6th arch artery defects
were randomly distributed in both Mesp1Cre conditional mutant
backgrounds, and there was no incidence of 3rd arch artery defects
in either conditional background. Equally importantly, the 4th pha-
ryngeal pouch defects seen in global Rara1/Rarb mutants and in Fox-
a2Cremcm/Rara403 embryos were not seen in mesoderm-speciﬁc
conditional mutants, even when arch arteries were obviously missing
(Fig. 2D–F). Furthermore, in late stage mesoderm-speciﬁc RAR mu-
tants, a normal distribution of calcitonin-expressing cells in the thy-
roid was observed (Suppl. Fig. 3C–D), implying normal
ultimobranchial body (4th pouch) morphogenesis, and thymus5, ink injection was ﬁrst used to visualize arch artery patterns, and then sections of the
different Foxa2Cremcm/Rara403 mutants, both have a normal 3rd pouch and a severely
(C). D,E, Two different Mesp1Cre/Rara1/Rxra mutants, both have normal 3rd and 4th
al pouch formation and an arch artery defect.
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ambiguously demonstrate that RA receptor function in mesoderm is
required for the formation of the 4th and 6th pharyngeal arch arter-
ies. These results additionally show that disruption of mesodermal
RAR function does not impact pharyngeal pouch development. Col-
lectively, these genetic manipulations uncouple mesodermal arch
artery development and endodermal 4th pouch development as in-
dependent and genetically separable processes.
The angiopoietin receptor Tie2 (TEK) is expressed in mature endo-
thelial cells. We used Tie2Cre (Kisanuki et al., 2001) to reﬁne the me-
sodermal requirement of RA signaling in arch artery morphogenesis.
In 14 Tie2Cre/Rara1/Rxra conditional mutants analyzed at E10.5 (by
ink injection), there were no defects in the pharyngeal arch arteries
(Table 1), and in 7 embryos analyzed at E14.5 (by histology), there
were no great vessel defects (not shown). Similarly, no defects in
the arch arteries were observed in 22 Tie2Cre/Rara403 embryos at
E10.5, nor great vessel defects in 6 embryos at E14.5. This outcome
may indicate that RA receptor function in arch artery development
occurs prior to or concurrent with terminal endothelial cell differen-
tiation and Tie2 expression; alternatively, RA receptor function
might occur in a non-endothelial mesodermal population of the arch.
Pharyngeal arch arteries form by vasculogenesis
Two alternative processes have been invoked to explain the initial
formation of the pharyngeal arch arteries. The angiogenesis model ar-
gues that the arch arteries form by sprouting from preexisting vessels
(e.g., the dorsal aortae or the outﬂow tract) into the pharyngeal arch
(Noden, 1990). The vasculogenesis model involves de novo differen-
tiation of endothelial cells in the center of the arch, which form an ini-
tial tube that then extends outward bidirectionally to ultimately meet
and fuse with the dorsal aorta and outﬂow tract (Anderson et al.,
2008). To our knowledge, these models have not yet been resolved
in mouse arch artery development. We used a number of molecular
markers to distinguish these processes in normal mouse embryosFig. 3. Caudal pharyngeal arch arteries form by vasculogenesis. Sagittal sections through no
orescence staining (A,C) and Tie2Cre/R26R Xgal staining (B,D). The brackets in all panels iden
arch and 4th arch artery. The embryos shown in B and D are different from but at the sameand in order to understand the basis of arch artery defects observed
in RAR mutants.
The VEGF receptor Vegfr2 (also known as Flk1) is expressed in endo-
thelial cell progenitors (angioblasts) early in their differentiation from
mesoderm;with further endothelial differentiation, these cells continue
to express Vegfr2 but also initiate expression of Pecam1 and of Tie2
(Ferguson et al., 2005). In normal embryos at E9.5, the 4th and 6th
arch arteries have not yet formed, and the endothelium of the dorsal
aortae and the 2nd and 3rd arch arteries were double positive for
Vegfr2 and Pecam1 (Fig. 3A), indicating that these are fully differentiat-
ed endothelial cells. Many Vegfr2+,Pecam1− angioblasts but no
Vegfr2+,Pecam1+ endothelial cells were present at E9.5 in the posteri-
or pharyngeal region where the 4th and 6th arch arteries will form
(bracketed region in Fig. 3A); the absence of Pecam1 expression iden-
tiﬁes these cells as angioblasts. At E9.75, Vegfr2+,Pecam1− cells were
still present in this caudal region, but in addition a number of
Vegfr2+,Pecam1+ cells were now present as isolated cells or in small
aggregations within the forming 4th arch (Fig. 3C). By E10.5, the 4th
and 6th arch arteries are functional and all endothelial cellswere double
positive for these markers. (Suppl. Fig. 4A). These observations imply
that the caudal pharyngeal arch arteries formby vasculogenesis. Our re-
sults are not compatible with a model of angiogenic sprouting from a
mature vessel into the arch, since such endothelial cells would be
Pecam1+ throughout the process of arch artery formation.
The Vegfr2+ angioblasts seen at E9.5 could be derived by de novo
mesodermal differentiation or by dedifferentiation of mature endothe-
lial cells. We used Tie2Cre to clarify the derivation of endothelial cells in
the pharyngeal arches. Tie2 is expressed beginning approximately coin-
cident with the onset of Pecam1 expression, but is not expressed in
Vegfr2+,Pecam1− angioblasts (Ferguson et al., 2005). Tie2Cre therefore
marks endothelial cells that are newly differentiated as well as those
derived from previously differentiated endothelium. In E9.5 Tie2Cre/
R26R embryos, the endothelium of the dorsal aorta and of the anteri-
or arch arteries was Xgal-positive, and there were no labeled cells in
the region of the future 4th and 6th arch arteries (Fig. 3B). At E9.75,rmal embryos at E9.5 (A,B) and E9.75 (C,D), showing Vegfr2 and Pecam1 immunoﬂu-
tify the region caudal to the 3rd arch, prior to (A,B) or during (C,D) formation of the 4th
developmental stage as those shown in A and C, respectively.
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not connected to the dorsal aorta or outﬂow tract (Fig. 3D). These
cells presumably correspond to the Vegfr2+,Pecam1+ cells seen in
the same location at the same time, as described above (Fig. 3C). If
the Vegfr2+,Pecam1− angioblasts at E9.5 in the caudal pharynx were
derived by dedifferentiation of mature endothelial cells (e.g., from the
dorsal aorta or from the outﬂow tract) that migrated into the arch
prior to their redifferentiation, they would remain Xgal+ throughout.
The absence of Xgal+ cells at E9.5 in the region where Vegfr2+ cells
are readily observed indicates instead that these cells arise by de novo
differentiation of pharyngeal mesoderm.
RA signaling regulates endothelial cell coalescence during arch artery
vasculogenesis
We compared control andMesp1Cre/Rara403 conditional embryos
to investigate the role of mesodermal RA signaling in endothelial cell
differentiation and arch artery formation. At E9.5–E10.0, in condition-
al dominant negative embryos, Vegfr2+,Pecam1− angioblasts were
observed in a similar number and distribution within the caudal
pharynx as in control embryos (Fig. 4A–D). At E9.75 and later stages,
a normal number of Vegfr2+,Pecam1+ differentiated endothelial cells
were also present (Fig. 4C–D). In all control embryos at E9.75,
Vegfr2+,Pecam1+ cells were aggregating to form a nascent blood
vessel (Fig. 4C). In mutants at E9.75, we observed a range of pheno-
types: in some cases, there was normal or relatively normal vessel
formation (not shown), whereas in others, the Vegfr2+,Pecam1+Fig. 4. Normal endothelial cell differentiation but altered vessel assembly in RAR mutants. A–
(A,B) and E9.75–10.0 (C,D) control vs. Mesp1Cre/Rara403 mutant embryos. These embryos
rows in A and B point to the very small number of double positive cells at this time. E–J, Tie2
for each embryo, three sections of a series are shown, selected for passing through the 3rd (
Xgal+ endothelial cells that failed to form the 6th arch artery in this mutant.endothelial cells remained mostly isolated and either failed to aggre-
gate or only formed small and scattered structures with small lumina
(Fig. 4D). Similarly, inMesp1Cre/Rara403mutant embryos at E10.5, all
Vegfr2+ cells were also positive for Pecam1, and scattered cells that
were not assembled into a vessel were readily observed in some
arches (Suppl. Fig. 4B). These results imply that the process of pha-
ryngeal mesoderm differentiation, ﬁrst to Vegfr2+ angioblasts and
then to Vegfr2+, Pecam1+ endothelial cells, occurs normally in RAR
mutants, but imply a variably penetrant defect in vascular formation
starting around E9.75. This timing is consistent with our temporal
analysis of RAR function using CAGG-Cre (Table 1), which implied a
requirement for RA signaling between E9.5 and E10.5.
To further examine this process, we evaluated Tie2Cre/R26R Xgal
staining in Rara1/Rarb global mutants. In E9.5 mutants, the staining
pattern in mutants was normal (e.g., with no stained cells caudal to
the 3rd arch artery as in Fig. 3B; not shown). In E10.5 control embry-
os, the 3rd–6th arch arteries have formed and all Xgal+ endothelial
cells were associated with functional vessels (Fig. 4E–G). In contrast,
in RAR mutants in the arches where vessels failed to form, Xgal+
cells remained unincorporated into vessels and persisted as scattered
cells (bracket in Fig. 4J). Our results suggest that RA signaling is not
required for terminal endothelial cell differentiation, but rather is re-
quired for Pecam1+ and Tie2+ endothelial cells in the pharyngeal
arches to coalesce into a nascent vessel.
Neural crest cells in the pharyngeal arches differentiate into the
smooth muscle of the arch arteries (Etchevers et al., 2001; Jiang et
al., 2000), a process that is necessary for stabilizing the newly formedD, Merged Vegfr2 (green) and Pecam1 (red) immunoﬂuorescence staining of E9.5–9.75
are slightly more advanced than the E9.5 and E9.75 stage embryos shown in Fig. 3. Ar-
Cre/R26R Xgal staining of a control (E–G) vs. a global Rara1/Rarbmutant (H–J) at E10.5;
E,H), 4th (F,I), and 6th (G,J) arch and arch artery. The bracket in (J) indicates scattered
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ral crest cell migration and distribution in Rara1/Rarb global mutants
(Jiang et al., 2002), and our observations of neural crest-speciﬁc RAR
mutants (Table 1) show that RA signaling in neural crest cells is not
necessary for arch artery development. InMesp1Cre/Rara403 embryos
at E10.5, we observed normal smooth muscle differentiation around
4th or 6th arch arteries that successfully formed, and no apparent
smooth muscle differentiation when these vessels failed to form
(Suppl. Fig. 5). These results suggest that the primary defect in
Mesp1Cre/Rara403 mutants is in arch artery formation, and that
smooth muscle differentiation by the neural crest depends on the ini-
tial formation of a vessel.
The arch artery phenotype of RARmutants is suggestive of a defect
in the process of endothelial cell adhesion and aggregation
(Vestweber et al., 2009). VE-cadherin (Cdh5) is an endothelium-
speciﬁc adhesion molecule that facilitates the establishment of
endothelial cell contacts and communication (Vestweber, 2008).
VE-cadherin is not expressed in angioblasts but is expressed in differ-
entiated endothelial cells. In control and Mesp1Cre/Rara403 condi-
tional mutant embryos, VE-cadherin was strongly expressed in
mature functional vascular structures, such as the dorsal aortae and
in properly formed pharyngeal arch arteries. In sections of control
embryos at E9.75, virtually all Vegfr2+ endothelial cells in the caudal
pharynx also expressed VE-cadherin (Fig. 5A). In conditional mutants,
some Vegfr2+ cells expressed VE-cadherin, although the majority of
Vegfr2+ cells did not (Fig. 5B). Dissociation of caudal pharyngeal
arch tissue at E10.0 conﬁrmed a reduced number of VE-cadherin+ en-
dothelial cells in mutant embryos (Suppl. Fig. 6). RA signaling in pha-
ryngeal angioblasts may regulate the expression of adhesion
molecules such as VE-cadherin and thereby control the assembly of
endothelial cells into pharyngeal blood vessels.
Discussion
The cellular and molecular events that lead to the formation of the
arch arteries have been unclear. In zebraﬁsh embryos, time-lapse cin-
ematography demonstrated the de novo appearance of Fli (the homo-
log of mammalian Vegfr2)-positive cells within each arch, rather thanFig. 5. Deﬁcient VE-cadherin expression in RAR mutants. Sections of E9.75 embryos are sho
4th pharyngeal arch. In the control embryo (A), virtually all Vegfr2+ cells are also VE-cadher
tant embryo (B), there are some Vegfr2+,VEcad+ cells (selected examples identiﬁed by arro
ples identiﬁed by arrowheads).the migration of Fli1+ cells into the arch, implying a vasculogenic
process (Anderson et al., 2008). Our results support a similar vasculo-
genic process in mouse embryos, based on the sequential appearance
of Vegfr2+,Pecam1− and then Vegfr2+,Pecam1+ cells prior to the
formation of the arch arteries. We also showed using Tie2CreR26R as
a lineage tracer that the initial arch artery endothelial progenitors
are not derived from a previously differentiated source. Our results
imply that mouse pharyngeal mesoderm undergoes vasculogenic dif-
ferentiation to generate Vegfr2+ angioblasts, and that these cells then
further differentiate and assemble into nascent vessels that ultimately
form the arch arteries. A variant of this model that we cannot formally
exclude is that Vegfr2+ angioblasts originate by mesodermal differ-
entiation elsewhere and then migrate into the pharyngeal arches,
where they then undergo further differentiation.
The primary focus of this study has been to address the role of reti-
noic acid signaling in this process. Prior studies argued that arch ar-
tery defects occur secondary to segmentation or signaling defects in
the pharyngeal endoderm (Mark et al., 2004, 2009; Wendling et al.,
2000). These models are contradicted by our genetic analysis, where
we show clearly that the endodermal and mesodermal functions of
RA signaling in pouch and arch artery formation are separable
and distinct. Speciﬁcally, the presence of arch artery defects and
the invariant absence of pouch defects in Mesp1Cre/Rara403 and
Mesp1Cre/Rara1/Rxra mutants demonstrate that arch artery mor-
phogenesis requires RA receptor function within the pharyngeal
mesoderm lineage. Similarly, in endoderm-speciﬁc RAR mutants,
we frequently recovered embryos in which a normal arch artery
pattern occurred even when there was no 4th pouch, indicating
that arch artery formation does not have an obligate dependence
on pharyngeal organization or segmentation, nor on RA signaling
in endoderm. We did see occasional examples of isolated arch ar-
tery defects in Foxa2Cremcm/Rara403 mutants with 4th pouch de-
fects. Possibly, the distortion of the pharyngeal architecture
caused by endodermal RAR mutation simply makes it less likely
for endothelial cells to aggregate and form an arch artery.
One of the unexpected outcomes of this analysis was the selective
impact of RAR disruption on only the caudal (4th and 6th) arch arter-
ies and the caudal (4th) pouch; defects in the 3rd arch arteries andwn labeled for Vegfr2 and VE-cadherin; the brackets indicate the region of the forming
in+ as well (selected cells are identiﬁed by arrows for comparison registry). In the mu-
ws), but the majority of Vegfr2+ cells are not expressing VE-cadherin (selected exam-
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experimental models of deﬁcient RA signaling noted the common oc-
currence of 3rd–6th pharyngeal arch, 3rd–6th arch artery, and 3rd–
4th pouch defects (Mark et al., 2004). It is unlikely that the absence
of 3rd arch artery and 3rd pouch defects in the mutants described
in our study is due to insufﬁcient recombination by Mesp1Cre and
Foxa2Cremcm in more anterior regions of the pharynx (Suppl. Fig. 2,
based on Xgal staining of R26R embryos; note also that R26R is allelic
to Rara403 so there should not be any difference in recombination ef-
ﬁciency between the two based on chromosomal location). A more
likely explanation is that 4th and 6th arch artery and 4th pouch for-
mation employ distinct regulatory programs involving retinoic acid
signaling in mesoderm and endoderm that are simply not required
for the formation of the more anterior pharyngeal region. One possi-
bility is that RA signaling in pharyngeal ectoderm or neuroectoderm
might support or augment 3rd arch artery and 3rd pouch morpho-
genesis. RA signaling in ectoderm is clearly important in hindbrain
patterning (Dupe et al., 1999; Serpente et al., 2005; Vitobello et al.,
2011; Wendling et al., 2001), although one study also presented evi-
dence that hindbrain patterning per se is not responsible for endoder-
mal or mesodermal pharyngeal defects (Niederreither et al., 2003). In
our analysis, we have not considered ectodermal RA signaling and so
cannot address the possibility of an ectodermal inﬂuence on anterior
pharyngeal morphogenesis.
In our study, Mesp1Cre/Rara403mutants survived to full term and
were of normal size. Although we did not undertake a careful analysis
outside of the pharyngeal arches, general vascular organization must
have been sufﬁcient to support organogenesis and overall embryo
growth, as also previously inferred (Wendling et al., 2000). Thus,
the vascular consequences of blocking mesodermal RA signaling
might not only exclude the 1st–3rd arch arteries within the pharynx,
but also exclude the rest of the embryo. Retinoic acid has been impli-
cated in several aspects of endothelial cell vasculogenesis and angio-
genesis (Pal et al., 2000; Ribes et al., 2007; Suzuki et al., 2004) and
smooth muscle differentiation and function (Kosaka et al., 2001;
Medhora, 2000; Miano et al., 1996; Wang et al., 2008). Our results
do not support the developmental importance of these observations,
at least within the recombination domain of Mesp1Cre for mesoderm
and ofWnt1Cre for neural crest (a subset of smooth muscle). Yolk sac
vasculogenesis has also been shown to be dependent on RA signaling
(Bohnsack et al., 2004; Lai et al., 2003), and this was clearly not com-
promised in Mesp1Cre/Rara403 mutants, although vasculogenesis in
the yolk sac may occur earlier than when Mesp1Cre becomes active.
Our results show that RA signaling is not involved in the differen-
tiation of pharyngeal mesoderm to Vegfr2+ angioblasts, nor in the
further differentiation of these angioblasts to Pecam1+ and Tie2+ en-
dothelium, at least insofar as the appearance of cells expressing these
markers was normal in mutant embryos. Rather, we observed a fail-
ure in endothelial cell assembly into nascent vessels as the process
that is compromised in RARmutants. Endothelial cells express several
types of adhesion molecules that support their aggregation and as-
sembly into functional vessels, including VE-cadherin (Cdh5), which
promotes lumen formation and maintains endothelial cell adherens
junctions (Vestweber et al., 2009). Cdh5 null mouse embryos have a
grossly impaired systemic vascular organization (Carmeliet et al.,
1999) and die at E9.5, prior to the formation of the caudal arch arter-
ies. Zebraﬁsh morphants in which VE-cadherin expression is elimi-
nated show a similar globally defective vascular phenotype, but
survive late enough to conﬁrm that the arch arteries are also poorly
formed (Montero-Balaguer et al., 2009). Deﬁcient VE-cadherin ex-
pression may therefore underlie the arch artery defect of RAR mu-
tants. At present, it is not clear how to interpret the deﬁciency of
VE-cadherin expression in 4th and 6th arch endothelial cells in
terms of the developmental role of RA signaling. One possibility is
that VE-cadherin may be part of a separate subprogram of differenti-
ation that is speciﬁcally regulated by RA, although RA does not controloverall pharyngeal endothelial differentiation (as deﬁned by Pecam1
and Tie2 expression). Alternatively, Cdh5 expression may be a tran-
scriptionally regulated aspect of gene expression in pharyngeal endo-
thelial cells. RA induces Cdh5 in a breast cancer cell line (Prahalad et
al., 2010), suggesting at least the possibility of a transcriptional rather
than differentiation role. If so, this mode of regulation must be nar-
rowly constrained to the time immediately upon endothelial cell dif-
ferentiation, as our genetic observations show no required function
for RARs in endothelial cells that express Tie2Cre.
Our results demonstrate a stochastic component to the process of
arch artery formation. In different RARmutant backgrounds, although
the frequency of arch artery defects varied, there was always a ran-
dom occurrence of 4th vs. 6th arch artery defects, and no association
between the left vs. right side of an embryo in terms of which vessel
formed. Our observations are compatible with a model in which a rate
limiting early step in the formation of an arch artery is the aggrega-
tion of a critical number of endothelial cells within an arch to form
a nascent vessel. The likelihood of endothelial cells to aggregate in
this manner might depend on the expression of VE-cadherin or
other adhesion or signaling molecules that are controlled by meso-
dermal RA signal transduction, and could be indirectly compromised
when pharyngeal architecture is altered (e.g., as in some Foxa2-
Cremcm/Rara403 embryos). The observation that some arch arteries
form even when mesodermal RA signaling is completely ablated
(e.g., in Mesp1Cre/Rara403 embryos) suggests that initial endothelial
cell aggregation is not absolutely dependent on RA signaling. Further-
more, once an initial aggregation of endothelial cells has successfully
occurred, subsequent processes presumably stabilize the vessel, allow
further angiogenic extension, and support VE-cadherin expression in
a way that no longer depends on RA.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.10.018.
Acknowledgments
This study was supported by NIH grant HL078891.
References
Anderson, M.J., Pham, V.N., Vogel, A.M., Weinstein, B.M., Roman, B.L., 2008. Loss of unc45a
precipitates arteriovenous shunting in the aortic arches. Dev. Biol. 318, 258–267.
Bayha, E., Jorgensen, M.C., Serup, P., Grapin-Botton, A., 2009. Retinoic acid signaling or-
ganizes endodermal organ speciﬁcation along the entire antero-posterior axis.
PLoS One 4, e5845.
Bohnsack, B.L., Lai, L., Dolle, P., Hirschi, K.K., 2004. Signaling hierarchy downstream of
retinoic acid that independently regulates vascular remodeling and endothelial
cell proliferation. Genes Dev. 18, 1345–1358.
Carmeliet, P., Lampugnani, M.G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Bal-
coni, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M., Zanetti, A., Angellilo, A., Mat-
tot, V., Nuyens, D., Lutgens, E., Clotman, F., de Ruiter, M.C., Gittenberger-de Groot,
A., Poelmann, R., Lupu, F., Herbert, J.M., Collen, D., Dejana, E., 1999. Targeted deﬁ-
ciency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-
mediated endothelial survival and angiogenesis. Cell 98, 147–157.
Chen, J., Kubalak, S.W., Chien, K.R., 1998. Ventricular muscle-restricted targeting of the
RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber
morphogenesis. Development 125, 1943–1949.
Dupe, V., Ghyselinck, N.B., Wendling, O., Chambon, P., Mark, M., 1999. Key roles of reti-
noic acid receptors alpha and beta in the patterning of the caudal hindbrain, pha-
ryngeal arches and otocyst in the mouse. Development 126, 5051–5059.
Etchevers, H.C., Vincent, C., Le Douarin, N.M., Couly, G.F., 2001. The cephalic neural
crest provides pericytes and smooth muscle cells to all blood vessels of the face
and forebrain. Development 128, 1059–1068.
Ferguson III, J.E., Kelley, R.W., Patterson, C., 2005. Mechanisms of endothelial differentia-
tion in embryonic vasculogenesis. Arterioscler. Thromb. Vasc. Biol. 25, 2246–2254.
Hayashi, S., McMahon, A.P., 2002. Efﬁcient recombination in diverse tissues by a
tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/
inactivation in the mouse. Dev. Biol. 244, 305–318.
Hiruma, T., Nakajima, Y., Nakamura, H., 2002. Development of pharyngeal arch arteries
in early mouse embryo. J. Anat. 201, 15–29.
Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., Sucov, H.M., 2000. Fate of the mam-
malian cardiac neural crest. Development 127, 1607–1616.
Jiang, X., Choudhary, B., Merki, E., Chien, K.R., Maxson, R.E., Sucov, H.M., 2002. Normal
fate and altered function of the cardiac neural crest cell lineage in retinoic acid re-
ceptor mutant embryos. Mech. Dev. 117, 115–122.
124 P. Li et al. / Developmental Biology 361 (2012) 116–124Kameda, Y., Nishimaki, T., Chisaka, O., Iseki, S., Sucov, H.M., 2007. Expression of the ep-
ithelial marker E-cadherin by thyroid C cells and their precursors during murine
development. J. Histochem. Cytochem. 55, 1075–1088.
Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson, J.A., Yanagisawa,
M., 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage anal-
ysis in vivo. Dev. Biol. 230, 230–242.
Kopinke, D., Sasine, J., Swift, J., Stephens, W.Z., Piotrowski, T., 2006. Retinoic acid is re-
quired for endodermal pouch morphogenesis and not for pharyngeal endoderm
speciﬁcation. Dev. Dyn. 235, 2695–2709.
Kosaka, C., Sasaguri, T., Komiyama, Y., Takahashi, H., 2001. All-trans retinoic acid in-
hibits vascular smooth muscle cell proliferation targeting multiple genes for
cyclins and cyclin-dependent kinases. Hypertens. Res. 24, 579–588.
Lai, L., Bohnsack, B.L., Niederreither, K., Hirschi, K.K., 2003. Retinoic acid regulates en-
dothelial cell proliferation during vasculogenesis. Development 130, 6465–6474.
Lee, R.Y., Luo, J., Evans, R.M., Giguere, V., Sucov, H.M., 1997. Compartment-selective
sensitivity of cardiovascular morphogenesis to combinations of retinoic acid recep-
tor gene mutations. Circ. Res. 80, 757–764.
Li, E., Sucov, H.M., Lee, K.F., Evans, R.M., Jaenisch, R., 1993. Normal development and
growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor
gene. Proc. Natl. Acad. Sci. U. S. A. 90, 1590–1594.
Li, P., Pashmforoush, M., Sucov, H.M., 2010. Retinoic acid regulates differentiation of the
secondary heart ﬁeld and TGFbeta-mediated outﬂow tract septation. Dev. Cell. 18,
480–485.
Luo, J., Pasceri, P., Conlon, R.A., Rossant, J., Giguere, V., 1995. Mice lacking all isoforms of
retinoic acid receptor beta develop normally and are susceptible to the teratogenic
effects of retinoic acid. Mech. Dev. 53, 61–71.
Mark, M., Ghyselinck, N.B., Chambon, P., 2004. Retinoic acid signalling in the develop-
ment of branchial arches. Curr. Opin. Genet. Dev. 14, 591–598.
Mark, M., Ghyselinck, N.B., Chambon, P., 2009. Function of retinoic acid receptors dur-
ing embryonic development. Nucl. Recept. Signal. 7, e002.
Matt, N., Ghyselinck, N.B., Wendling, O., Chambon, P., Mark, M., 2003. Retinoic acid-
induced developmental defects are mediated by RARbeta/RXR heterodimers in
the pharyngeal endoderm. Development 130, 2083–2093.
Medhora, M.M., 2000. Retinoic acid upregulates beta(1)-integrin in vascular smooth
muscle cells and alters adhesion to ﬁbronectin. Am. J. Physiol. Heart Circ. Physiol.
279, H382–H387.
Mendelsohn, C., Lohnes, D., Decimo, D., Lufkin, T., LeMeur, M., Chambon, P., Mark, M.,
1994. Function of the retinoic acid receptors (RARs) during development (II). Mul-
tiple abnormalities at various stages of organogenesis in RAR double mutants. De-
velopment 120, 2749–2771.
Miano, J.M., Topouzis, S., Majesky, M.W., Olson, E.N., 1996. Retinoid receptor expres-
sion and all-trans retinoic acid-mediated growth inhibition in vascular smooth
muscle cells. Circulation 93, 1886–1895.
Montero-Balaguer, M., Swirsding, K., Orsenigo, F., Cotelli, F., Mione, M., Dejana, E., 2009.
Stable vascular connections and remodeling require full expression of VE-cadherin
in zebraﬁsh embryos. PLoS One 4, e5772.
Mulder, G.B., Manley, N., Maggio-Price, L., 1998. Retinoic acid-induced thymic abnormali-
ties in themouse are associatedwith altered pharyngealmorphology, thymocytemat-
uration defects, and altered expression of Hoxa3 and Pax1. Teratology 58, 263–275.
Niederreither, K., Vermot, J., Le Roux, I., Schuhbaur, B., Chambon, P., Dolle, P., 2003. The
regional pattern of retinoic acid synthesis by RALDH2 is essential for the develop-
ment of posterior pharyngeal arches and the enteric nervous system. Development
130, 2525–2534.Noden, D.M., 1990. Origins and assembly of avian embryonic blood vessels. Ann. N. Y.
Acad. Sci. 588, 236–249.
Pal, S., Iruela-Arispe, M.L., Harvey, V.S., Zeng, H., Nagy, J.A., Dvorak, H.F., Mukhopad-
hyay, D., 2000. Retinoic acid selectively inhibits the vascular permeabilizing effect
of VPF/VEGF, an early step in the angiogenic cascade. Microvasc. Res. 60, 112–120.
Park, E.J., Sun, X., Nichol, P., Saijoh, Y., Martin, J.F., Moon, A.M., 2008. System for
tamoxifen-inducible expression of cre-recombinase from the Foxa2 locus in
mice. Dev. Dyn. 237, 447–453.
Prahalad, P., Dakshanamurthy, S., Ressom, H., Byers, S.W., 2010. Retinoic acid mediates
regulation of network formation by COUP-TFII and VE-cadherin expression by
TGFbeta receptor kinase in breast cancer cells. PLoS One 5, e10023.
Rajaii, F., Bitzer, Z.T., Xu, Q., Sockanathan, S., 2008. Expression of the dominant negative
retinoid receptor, RAR403, alters telencephalic progenitor proliferation, survival,
and cell fate speciﬁcation. Dev. Biol. 316, 371–382.
Ribes, V., Otto, D.M., Dickmann, L., Schmidt, K., Schuhbaur, B., Henderson, C., Blomhoff,
R., Wolf, C.R., Tickle, C., Dolle, P., 2007. Rescue of cytochrome P450 oxidoreductase
(Por) mouse mutants reveals functions in vasculogenesis, brain and limb pattern-
ing linked to retinoic acid homeostasis. Dev. Biol. 303, 66–81.
Saga, Y., Miyagawa-Tomita, S., Takagi, A., Kitajima, S., Miyazaki, J., Inoue, T., 1999.
MesP1 is expressed in the heart precursor cells and required for the formation of
a single heart tube. Development 126, 3437–3447.
Serpente, P., Tumpel, S., Ghyselinck, N.B., Niederreither, K., Wiedemann, L.M., Dolle, P.,
Chambon, P., Krumlauf, R., Gould, A.P., 2005. Direct crossregulation between reti-
noic acid receptor beta and Hox genes during hindbrain segmentation. Develop-
ment 132, 503–513.
Soriano, P., 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat.
Genet. 21, 70–71.
Suzuki, Y., Komi, Y., Ashino, H., Yamashita, J., Inoue, J., Yoshiki, A., Eichmann, A., Ama-
numa, H., Kojima, S., 2004. Retinoic acid controls blood vessel formation by modu-
lating endothelial and mural cell interaction via suppression of Tie2 signaling in
vascular progenitor cells. Blood 104, 166–169.
Vestweber, D., 2008. VE-cadherin: the major endothelial adhesion molecule controlling
cellular junctions and blood vessel formation. Arterioscler. Thromb. Vasc. Biol. 28,
223–232.
Vestweber, D., Winderlich, M., Cagna, G., Nottebaum, A.F., 2009. Cell adhesion dynam-
ics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 19,
8–15.
Vitobello, A., Ferretti, E., Lampe, X., Vilain, N., Ducret, S., Ori, M., Spetz, J.F., Selleri, L.,
Rijli, F.M., 2011. Hox and Pbx factors control retinoic acid synthesis during hind-
brain segmentation. Dev. Cell. 20, 469–482.
Waldo, K.L., Kumiski, D., Kirby, M.L., 1996. Cardiac neural crest is essential for the per-
sistence rather than the formation of an arch artery. Dev. Dyn. 205, 281–292.
Wang, C., Han, M., Zhao, X.M., Wen, J.K., 2008. Kruppel-like factor 4 is required for the
expression of vascular smooth muscle cell differentiation marker genes induced by
all-trans retinoic acid. J. Biochem. 144, 313–321.
Wendling, O., Dennefeld, C., Chambon, P., Mark, M., 2000. Retinoid signaling is essential
for patterning the endoderm of the third and fourth pharyngeal arches. Develop-
ment 127, 1553–1562.
Wendling, O., Ghyselinck, N.B., Chambon, P., Mark, M., 2001. Roles of retinoic acid re-
ceptors in early embryonic morphogenesis and hindbrain patterning. Develop-
ment 128, 2031–2038.
Wilson, J.G., Warkany, J., 1949. Aortic-arch and cardiac anomalies in the offspring of vi-
tamin A deﬁcient rats. Am. J. Anat. 85, 113–155.
